Abstract:Mechanical allodynia, characterized by a painful sensation induced by innocuous stimuli, is thought to be caused by disruption in pain-related regions. Identification and reversal of this pathologic neuroadaptation are therefore beneficial for clinical treatment. Previous evidence suggests that 5-HT6 receptors in the ventrolateral orbital cortex (VLO) are involved in neuropathic pain, but their function is poorly understood. The aim of the present study is to unveil the role of 5-HT6 receptors in the VLO and the underlying mechanisms in pain modulation. Here, by using the spared nerve injury (SNI) pain model, first, we report that 5-HT6 receptor protein decreased in the contralateral VLO compared with the ipsilateral VLO in rats with allodynia. Second, microinjection of the selective 5-HT6 receptor agonists EMD-386088 and WAY-208466 into the contralateral VLO consistently and significantly depressed allodynia. Third, microinjection of the selective antagonist SB-258585 blocked the agonist-induced anti-allodynic effect, while the antagonist applied alone to the VLO had no effect. Furthermore, the anti-nociceptive effect of EMD-386088 on neuropathic pain was prevented by the adenylate cyclase (AC) inhibitor SQ-22536, and protein kinase A (PKA) inhibitor H89, suggesting that AC/PKA signaling might underlie the antinociception of agonists. Finally, the 5-HT6 receptors were found to be colocalized with a glutamate transporter (EAAC1) by immunofluorescent staining, and the glutamate receptor antagonist kynurenic acid was found to completely block antinociception. These findings indicated that the antinociceptive effect of 5-HT6 receptor agonists might occur via interaction with the glutamatergic system. Altogether, the agonists activated 5-HT6 receptors present in the glutamatergic neurons in the VLO to facilitate the AC/PKA cascade, which subsequently might evoke glutamate release, thus depressing allodynia. These findings suggest a potential therapeutic role of 5-HT6 receptor agonists in treating neuropathic pain.

Involvement of 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors in mediating the ventrolateral orbital cortex-induced antiallodynia in a rat model of neuropathic pain

Involvement of Ventrolateral Orbital Cortex 5-HT 1–7 Receptors in 5-HT Induced Depression of Spared Nerve Injury Allodynia

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

The 5-HT6 Receptors in the Ventrolateral Orbital Cortex Attenuate Allodynia in a Rodent Model of Neuropathic Pain

mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model

The Role of Dopamine Receptors in Ventrolateral Orbital Cortex-Evoked Anti-Nociception in A Rat Model of Neuropathic Pain

Activation of 5-HT5A Receptor in the Ventrolateral Orbital Cortex Produces Antinociceptive Effects in Rat Models of Neuropathic and Inflammatory Pain

The Role of Α2 Adrenoceptor in Mediating Noradrenaline Action in the Ventrolateral Orbital Cortex on Allodynia Following Spared Nerve Injury

Activation of Α1 Adrenoceptors in Ventrolateral Orbital Cortex Attenuates Allodynia Induced by Spared Nerve Injury in Rats.

The Pronociceptive Role of 5-HT6 Receptors in Ventrolateral Orbital Cortex in a Rat Formalin Test Model.

IL-10 and IL-1β Mediate Neuropathic-Pain Like Behavior in the Ventrolateral Orbital Cortex

The role of dopamine receptors in ventrolateral orbital cortex-evoked antinociception in a rat formalin test model.

The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats

Involvement of 5-hydroxytryptamine1A receptors in the descending anti-nociceptive pathway from periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve injury and rats with inflammation

GABAergic Modulation is Involved in the Ventrolateral Orbital Cortex 5-HT 1A Receptor Activation-Induced Antinociception in the Rat.

Activation of CB1 Receptors on GABAergic Interneurons in the Ventrolateral Orbital Cortex Induces Analgesia

Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antinociceptive effect in a rat of neuropathic pain

Activation of 5-HT6 Receptors in the Ventrolateral Orbital Cortex Produces Anti-Anxiodepressive Effects in a Rat Model of Neuropathic Pain

D2-like but Not D1-like Dopamine Receptors Are Involved in the Ventrolateral Orbital Cortex-Induced Antinociception: a GABAergic Modulation Mechanism.

Activation of ventrolateral orbital cortex improves mouse neuropathic pain–induced anxiodepression

$mu; but not $delta; and $kappa; opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats